Charles Burger, MD: Pulmonary hypertension really refers to a state where the right heart is generating high pressures to circulate the blood through the lung. Pulmonary arterial hypertension is a ...
Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and a ...
"Taken together the interplay of sex-specific gene regulation and its impact on ECM-related genes, influenced by factors such as genetics, epigenetics, environmental exposures, steroid hormones, aging ...
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by arteriopathy in the small to medium-sized distal pulmonary arteries, often accompanied by infiltration of inflammatory ...
—Investigators from the U.S. and U.K have identified neutrophil elastase (NE) and its inhibitor elafin as possible biomarkers in the pathogenesis of pulmonary arterial hypertension (PAH). “An ...
Alterations in metabolism of lipids, amino acids, glucose, nucleotides, and pulmonary and gut microbiome play a crucial role in COPD development. These metabolites have great potential as early ...
Further investigation on the pathogenesis and treatment of patients with schistosome-associated pulmonary arterial hypertension (Sch-PAH) may lead to improved symptoms and higher rates of survival. A ...
Few threats to public health are as perilous as cigarette smoking, with more than 435,000 Americans dying each year of tobacco-related pulmonary illnesses such as chronic obstructive pulmonary disease ...
The Pulmonary, Critical Care, and Sleep Medicine Section has strong nationally recognized research programs in lung diseases and critical care medicine. The faculty performs a broad spectrum of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results